7/1/2022  12:02:31 PM Chg. +0.110 Volume Bid3:35:43 PM Ask3:35:43 PM Market Capitalization Dividend Y. P/E Ratio
3.490EUR +3.25% 88
Turnover: 307.060
3.260Bid Size: 1,425 3.500Ask Size: 1,425 14.06 mill.EUR 0.00% -

Business description

CytoTools AG is a biotechnology company focused on translating fundamental biology research on the mechanisms of cell growth and programmed cell death into unique therapies that are designed to treat the cause of the disease rather than the symptoms. The Company has developed a robust and diverse pipeline of disease modifying therapies that comprise proprietary small molecules and biologics. These have the potential to provide new treatment options in dermatology, cardiology and angiology, urology and oncology.
 

Management board & Supervisory board

CEO
Dr. Mark-Andre Freyberg
Management board
Marc Herwick, Dr. Dirk Kaiser
Supervisory board
Dr. Bernhard Seehaus, Dr. Manfred May, Dr. Rüdiger Weseloh, Heiner Hoppmann, Matthias Hoffmann
 

Company data

Name: CytoTools AG
Address: Klappacher Straße 126,D-64285 Darmstadt
Phone: +49-6151-951-5812
Fax: +49-6151-951-5813
E-mail: kontakt@cytotools.de
Internet: www.cytotools.de/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 53.00%
IPO date: -

Investor relations

Name: Dr. Mark-Andre Freyberg
IR phone: -
IR Fax: -
IR e-mail: -

Main Shareholders

Freefloat
 
53.00%
Organbesitz
 
47.00%